Hemodynamic support of a 15-year-old waiting for a heart transplant: Is there a role for levosimendan in pediatric heart failure?

Goyer, I; Brossier, D; Toledano, B

Goyer, I; Brossier, D; Toledano, B.

Affiliation

Goyer I; Department of pharmacy, CHU Sainte-Justine, 3175 Côte-Ste-Catherine, H3T1C5 Montreal, QC, Canada. Electronic address: isabelle.goyer@umontreal.ca.
Brossier D; Department of pediatric intensive care unit, CHU de Caen, avenue de la Côte-de-Nacre, 14033 Caen, France.
Toledano B; Department of pediatrics, university of Montreal, CHU Sainte-Justine, 3175 Côte-Ste-Catherine, H3T1C5 Montreal, QC, Canada.

Arch Pediatr ; 25(2): 132-135, 2018 Feb.

Article in En | MEDLINE | ID: mdl-29395891

Subject(s)

Cardiotonic Agents/therapeutic use; Heart Failure/drug therapy; Hydrazones/therapeutic use; Pyridazines/therapeutic use; Adolescent; Heart Failure/physiopathology; Heart Failure/surgery; Heart Transplantation; Hemodynamics; Humans; Intensive Care Units, Pediatric; Male; Simendan

Key words

Heart failure; Levosimendan; Pediatrics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridazines / Cardiotonic Agents / Heart Failure / Hydrazones Limits: Adolescent / Humans / Male Language: En Journal: Arch Pediatr Year: 2018 Document type: Article Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google